Literature DB >> 30507610

Bacterial sepsis triggers an antiviral response that causes translation shutdown.

Takashi Hato1, Bernhard Maier1, Farooq Syed2, Jered Myslinski1, Amy Zollman1, Zoya Plotkin1, Michael T Eadon1, Pierre C Dagher1,3,4.   

Abstract

In response to viral pathogens, the host upregulates antiviral genes that suppress translation of viral mRNAs. However, induction of such antiviral responses may not be exclusive to viruses, as the pathways lie at the intersection of broad inflammatory networks that can also be induced by bacterial pathogens. Using a model of Gram-negative sepsis, we show that propagation of kidney damage initiated by a bacterial origin ultimately involves antiviral responses that result in host translation shutdown. We determined that activation of the eukaryotic translation initiation factor 2-α kinase 2/eukaryotic translation initiation factor 2α (Eif2ak2/Eif2α) axis is the key mediator of translation initiation block in late-phase sepsis. Reversal of this axis mitigated kidney injury. Furthermore, temporal profiling of the kidney translatome revealed that multiple genes involved in formation of the initiation complex were translationally altered during bacterial sepsis. Collectively, our findings imply that translation shutdown is indifferent to the specific initiating pathogen and is an important determinant of tissue injury in sepsis.

Entities:  

Keywords:  Inflammation; Nephrology; Proteomics; Translation

Mesh:

Substances:

Year:  2018        PMID: 30507610      PMCID: PMC6307966          DOI: 10.1172/JCI123284

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation.

Authors:  Sabrina Ingrand; Laurence Barrier; Claire Lafay-Chebassier; Bernard Fauconneau; Guylène Page; Jacques Hugon
Journal:  FEBS Lett       Date:  2007-08-21       Impact factor: 4.124

2.  Two-Photon Intravital Fluorescence Lifetime Imaging of the Kidney Reveals Cell-Type Specific Metabolic Signatures.

Authors:  Takashi Hato; Seth Winfree; Richard Day; Ruben M Sandoval; Bruce A Molitoris; Mervin C Yoder; Roger C Wiggins; Yi Zheng; Kenneth W Dunn; Pierre C Dagher
Journal:  J Am Soc Nephrol       Date:  2017-03-01       Impact factor: 10.121

Review 3.  Sepsis: current dogma and new perspectives.

Authors:  Clifford S Deutschman; Kevin J Tracey
Journal:  Immunity       Date:  2014-04-17       Impact factor: 31.745

Review 4.  Functional 5' UTR mRNA structures in eukaryotic translation regulation and how to find them.

Authors:  Kathrin Leppek; Rhiju Das; Maria Barna
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

5.  Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation.

Authors:  Valentina Gandin; Annarita Miluzio; Anna Maria Barbieri; Anne Beugnet; Hiroaki Kiyokawa; Pier Carlo Marchisio; Stefano Biffo
Journal:  Nature       Date:  2008-09-10       Impact factor: 49.962

6.  Comparative genetics. Systematic discovery of cap-independent translation sequences in human and viral genomes.

Authors:  Shira Weingarten-Gabbay; Shani Elias-Kirma; Ronit Nir; Alexey A Gritsenko; Noam Stern-Ginossar; Zohar Yakhini; Adina Weinberger; Eran Segal
Journal:  Science       Date:  2016-01-14       Impact factor: 47.728

Review 7.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

8.  DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth.

Authors:  Katrin Strassburger; Philipp Christoph Janiesch; Sibylle Schleich; Tatyana Koledachkina; Katharine K Miller; Katharina Haneke; Yong-Sheng Cheng; Katrin Kuechler; Georg Stoecklin; Kent E Duncan; Aurelio A Teleman
Journal:  Nature       Date:  2014-07-06       Impact factor: 49.962

9.  Novel role of PKR in inflammasome activation and HMGB1 release.

Authors:  Ben Lu; Takahisa Nakamura; Karen Inouye; Jianhua Li; Yiting Tang; Peter Lundbäck; Sergio I Valdes-Ferrer; Peder S Olofsson; Thomas Kalb; Jesse Roth; Yongrui Zou; Helena Erlandsson-Harris; Huan Yang; Jenny P-Y Ting; Haichao Wang; Ulf Andersson; Daniel J Antoine; Sangeeta S Chavan; Gökhan S Hotamisligil; Kevin J Tracey
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

10.  RiboProfiling: a Bioconductor package for standard Ribo-seq pipeline processing.

Authors:  Alexandra Popa; Kevin Lebrigand; Agnes Paquet; Nicolas Nottet; Karine Robbe-Sermesant; Rainer Waldmann; Pascal Barbry
Journal:  F1000Res       Date:  2016-06-09
View more
  17 in total

1.  Targeting protein translation to prevent septic kidney injury.

Authors:  Sarah C Huen
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration.

Authors:  Masaki Uchida; Bernhard Maier; Hitesh Kumar Waghwani; Ekaterina Selivanovitch; S Louise Pay; John Avera; EJun Yun; Ruben M Sandoval; Bruce A Molitoris; Amy Zollman; Trevor Douglas; Takashi Hato
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

3.  Renal tubular cell spliced X-box binding protein 1 (Xbp1s) has a unique role in sepsis-induced acute kidney injury and inflammation.

Authors:  Silvia Ferrè; Yingfeng Deng; Sarah C Huen; Christopher Y Lu; Philipp E Scherer; Peter Igarashi; Orson W Moe
Journal:  Kidney Int       Date:  2019-08-01       Impact factor: 10.612

4.  Nicotinamide Mononucleotide Administration Triggers Macrophages Reprogramming and Alleviates Inflammation During Sepsis Induced by Experimental Peritonitis.

Authors:  Cécile Cros; Marielle Margier; Hélène Cannelle; Julie Charmetant; Nicolas Hulo; Laurent Laganier; Alessia Grozio; Matthias Canault
Journal:  Front Mol Biosci       Date:  2022-06-27

5.  A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease.

Authors:  Harini Ramalingam; Sonu Kashyap; Patricia Cobo-Stark; Andrea Flaten; Chun-Mien Chang; Sachin Hajarnis; Kyaw Zaw Hein; Jorgo Lika; Gina M Warner; Jair M Espindola-Netto; Ashwani Kumar; Mohammed Kanchwala; Chao Xing; Eduardo N Chini; Vishal Patel
Journal:  Cell Metab       Date:  2021-04-13       Impact factor: 31.373

Review 6.  The application of omic technologies to research in sepsis-associated acute kidney injury.

Authors:  Denise Hasson; Stuart L Goldstein; Stephen W Standage
Journal:  Pediatr Nephrol       Date:  2020-04-30       Impact factor: 3.714

Review 7.  Energetic dysfunction in sepsis: a narrative review.

Authors:  Sebastien Preau; Dominique Vodovar; Boris Jung; Steve Lancel; Lara Zafrani; Aurelien Flatres; Mehdi Oualha; Guillaume Voiriot; Youenn Jouan; Jeremie Joffre; Fabrice Uhel; Nicolas De Prost; Stein Silva; Eric Azabou; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2021-07-03       Impact factor: 6.925

8.  Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated with Infectious Systemic Inflammatory Response Syndromes.

Authors:  Shusuke Mori; Tomohiko Ai; Toshiki Sera; Kanae Ochiai; Yasuhiro Otomo
Journal:  J Clin Med       Date:  2019-09-27       Impact factor: 4.241

9.  Extensive Changes in Transcriptomic "Fingerprints" and Immunological Cells in the Large Organs of Patients Dying of Acute Septic Shock and Multiple Organ Failure Caused by Neisseria meningitidis.

Authors:  Berit Sletbakk Brusletto; Else Marit Løberg; Bernt Christian Hellerud; Ingeborg Løstegaard Goverud; Jens Petter Berg; Ole Kristoffer Olstad; Unni Gopinathan; Petter Brandtzaeg; Reidun Øvstebø
Journal:  Front Cell Infect Microbiol       Date:  2020-02-19       Impact factor: 5.293

10.  Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis.

Authors:  Zhiwen Liu; Danyi Yang; Jingli Gao; Xiaohong Xiang; Xiaoru Hu; Siyao Li; Wenwen Wu; Juan Cai; Chengyuan Tang; Dongshan Zhang; Zheng Dong
Journal:  Theranostics       Date:  2020-10-25       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.